Form 8-K - Current report:
SEC Accession No. 0001193125-13-103130
Filing Date
2013-03-12
Accepted
2013-03-12 16:08:33
Documents
3
Period of Report
2013-03-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d497114d8k.htm 8-K 16480
2 EX-99.1 d497114dex991.htm EX-99.1 77364
3 GRAPHIC g497114g72k27.jpg GRAPHIC 3373
  Complete submission text file 0001193125-13-103130.txt   100050
Mailing Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034
Business Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 13684242
SIC: 2834 Pharmaceutical Preparations